ACADIA PHARMACEUTICALS INC — Director's Dealing 2020

Jan 8, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ACADIA PHARMACEUTICALS INC (ACAD)
CIK: 0001070494
Period of Report: 2020-01-06

Reporting Person: YANG MICHAEL J. (EVP and CCO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-01-06	Stock Options (Right to Buy)	$42.81	A	39516	Acquired	2030-01-06	Common Stock (39516)	Direct
2020-01-06	Restricted Stock Units	$	A	10889	Acquired		Common Stock (10889)	Direct

Footnotes

F1: 25% of the shares subject to the Stock Option will vest and become exercisable on January 6, 2021. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter.

F2: Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock.

F3: The restricted stock units vest in four equal annual installments beginning January 6, 2021.